{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:13:28Z","timestamp":1783109608021,"version":"3.54.6"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.biomaterials.2023.122257","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T20:25:35Z","timestamp":1690316735000},"page":"122257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy"],"prefix":"10.1016","volume":"301","author":[{"given":"Mengyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5658-8163","authenticated-orcid":false,"given":"Dawei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.biomaterials.2023.122257_bib1","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1039\/D0CS01370F","article-title":"Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies","volume":"50","author":"Xie","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122257_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2023.122257_bib3","article-title":"Dually enhanced phototherapy by gambogic acid and hyperthemia-activated chemotherapy for synergistic breast cancer treatment","volume":"452","author":"Wang","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122257_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002104","article-title":"Immune checkpoint inhibitor-based strategies for synergistic cancer therapy","volume":"10","author":"He","year":"2021","journal-title":"Adv. Healthcare Mater."},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122257_bib5","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1039\/C7CS00594F","article-title":"Supramolecular photosensitizers rejuvenate photodynamic therapy","volume":"47","author":"Li","year":"2018","journal-title":"Chem. Soc. Rev."},{"issue":"36","key":"10.1016\/j.biomaterials.2023.122257_bib6","doi-asserted-by":"crossref","first-page":"11522","DOI":"10.1002\/anie.201805138","article-title":"Innovative strategies for hypoxic-tumor photodynamic therapy","volume":"57","author":"Li","year":"2018","journal-title":"Angew. Chem., Int. Ed."},{"issue":"18","key":"10.1016\/j.biomaterials.2023.122257_bib7","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1002\/anie.201814730","article-title":"A semiconducting polymer nano-prodrug for hypoxia-activated photodynamic cancer therapy","volume":"58","author":"Cui","year":"2019","journal-title":"Angew. Chem., Int. Ed."},{"issue":"17","key":"10.1016\/j.biomaterials.2023.122257_bib8","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1039\/D2BM00776B","article-title":"A chemical biology toolbox to overcome the hypoxic tumor microenvironment for photodynamic therapy: a review","volume":"10","author":"Zheng","year":"2022","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122257_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41427-021-00303-1","article-title":"Strategies to improve photodynamic therapy efficacy by relieving the tumor hypoxia environment","volume":"13","author":"Shen","year":"2021","journal-title":"NPG Asia Mater."},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122257_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2023.122257_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119702","article-title":"Long circulating photoactivable nanomicelles with tumor localized activation and ROS triggered self-accelerating drug release for enhanced locoregional chemo-photodynamic therapy","volume":"232","author":"Uthaman","year":"2020","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122257_bib12","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1021\/acsnano.7b08219","article-title":"Light-activatable red blood cell membrane-camouflaged dimeric prodrug nanoparticles for synergistic photodynamic\/chemotherapy","volume":"12","author":"Pei","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2023.122257_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2021.09.023","article-title":"Hypoxia-responsive block copolymer polyprodrugs for complementary photodynamic-chemotherapy","volume":"339","author":"Zhou","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2023.122257_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2016.11.006","article-title":"Drug-induced Co-assembly of albumin\/catalase as smart nano-theranostics for deep intra-tumoral penetration, hypoxia relieve, and synergistic combination therapy","volume":"263","author":"Chen","year":"2017","journal-title":"J. Contr. Release"},{"issue":"17","key":"10.1016\/j.biomaterials.2023.122257_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201900212","article-title":"Light-induced ROS generation and 2-DG-activated endoplasmic reticulum stress by antitumor nanosystems: an effective combination therapy by regulating the tumor microenvironment","volume":"15","author":"Dong","year":"2019","journal-title":"Small"},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122257_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805955","article-title":"Selectively potentiating hypoxia levels by combretastatin A4 nanomedicine: toward highly enhanced hypoxia-activated prodrug tirapazamine therapy for metastatic tumors","volume":"31","author":"Yang","year":"2019","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122257_bib17","article-title":"Recent progress in the design of hypoxia-specific Nano drug delivery systems for cancer therapy","volume":"1","author":"Sahu","year":"2018","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122257_bib18","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41467-019-09389-2","article-title":"Perfluorocarbon regulates the intratumoural environment to enhance hypoxia-based agent efficacy","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122257_bib19","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1021\/acsnano.6b08731","article-title":"Tumor-penetrating nanoparticles for enhanced anticancer activity of combined photodynamic and hypoxia-activated therapy","volume":"11","author":"Wang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2023.122257_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biomaterials.2016.11.057","article-title":"Mesoporous silica-based versatile theranostic nanoplatform constructed by layer-by-layer assembly for excellent photodynamic\/chemo therapy","volume":"117","author":"Chen","year":"2017","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122257_bib21","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1039\/C9BM00634F","article-title":"ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy","volume":"7","author":"Liu","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biomaterials.2023.122257_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121425","article-title":"Engineered nanomaterials for synergistic photo-immunotherapy","volume":"282","author":"Guo","year":"2022","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122257_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12499","article-title":"Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy","volume":"7","author":"He","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2023.122257_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121433","article-title":"Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy","volume":"282","author":"Zhang","year":"2022","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122257_bib25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.drudis.2020.11.029","article-title":"Nanodelivery of immunogenic cell death-inducers for cancer immunotherapy","volume":"26","author":"Sun","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biomaterials.2023.122257_bib26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jconrel.2022.08.054","article-title":"Self-activated arsenic manganite nanohybrids for visible and synergistic thermo\/immuno-arsenotherapy","volume":"350","author":"Zhai","year":"2022","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122257_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122257_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O'Donnell","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122257_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","article-title":"A paradigm shift in cancer immunotherapy: from enhancement to normalization","volume":"175","author":"Sanmamed","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122257_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt0415-321","article-title":"Ido inhibitors move center stage in immuno-oncology","volume":"33","author":"Sheridan","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2023.122257_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2019.05.008","article-title":"Platelets as platforms for inhibition of tumor recurrence post-physical therapy by delivery of anti-PD-L1 checkpoint antibody","volume":"304","author":"Han","year":"2019","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122257_bib32","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7150\/thno.67300","article-title":"Recent advances in nanomedicines for photodynamic therapy (PDT)-Driven cancer immunotherapy","volume":"12","author":"Ji","year":"2022","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122257_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202007149","article-title":"Metformin mediated PD-L1 downregulation in combination with photodynamic-immunotherapy for treatment of breast cancer","volume":"31","author":"Hu","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"43","key":"10.1016\/j.biomaterials.2023.122257_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202102668","article-title":"Engineering chameleon prodrug nanovesicles to increase antigen presentation and inhibit PD-L1 expression for circumventing immune resistance of cancer","volume":"33","author":"Zhou","year":"2021","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.biomaterials.2023.122257_bib35","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1021\/jacs.9b12788","article-title":"Engineering of upconverted metal\u2013organic frameworks for near-infrared light-triggered combinational photodynamic\/chemo-\/immunotherapy against hypoxic tumors","volume":"142","author":"Shao","year":"2020","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122257_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1021\/acs.nanolett.9b04012","article-title":"Sheddable prodrug vesicles combating adaptive immune resistance for improved photodynamic immunotherapy of cancer","volume":"20","author":"Gao","year":"2020","journal-title":"Nano Lett."},{"issue":"19","key":"10.1016\/j.biomaterials.2023.122257_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202008125","article-title":"Cationic flexible organic framework for combination of photodynamic therapy and genetic immunotherapy against tumors","volume":"17","author":"Hao","year":"2021","journal-title":"Small"},{"issue":"13","key":"10.1016\/j.biomaterials.2023.122257_bib38","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.7150\/thno.15433","article-title":"ROS-responsive mitochondria-targeting blended nanoparticles: chemo- and photodynamic synergistic therapy for lung cancer with on-demand drug release upon irradiation with a single light source","volume":"6","author":"Yue","year":"2016","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122257_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1208\/s12249-013-0041-3","article-title":"Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy","volume":"15","author":"Ding","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"10.1016\/j.biomaterials.2023.122257_bib40","doi-asserted-by":"crossref","first-page":"17100","DOI":"10.1021\/acsnano.0c06765","article-title":"Self-delivery photo-immune stimulators for photodynamic sensitized tumor immunotherapy","volume":"14","author":"Zhao","year":"2020","journal-title":"ACS Nano"},{"issue":"49","key":"10.1016\/j.biomaterials.2023.122257_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201906805","article-title":"Phase-change materials based nanoparticles for controlled hypoxia modulation and enhanced phototherapy","volume":"29","author":"Zhang","year":"2019","journal-title":"Adv. Funct. Mater."},{"issue":"32","key":"10.1016\/j.biomaterials.2023.122257_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201901896","article-title":"Tumor microenvironment-responsive dual drug dimer-loaded PEGylated bilirubin nanoparticles for improved drug delivery and enhanced immune-chemotherapy of breast cancer","volume":"29","author":"Yang","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2023.122257_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.actbio.2014.11.041","article-title":"Hydrophobic IR780 encapsulated in biodegradable human serum albumin nanoparticles for photothermal and photodynamic therapy","volume":"14","author":"Jiang","year":"2015","journal-title":"Acta Biomater."},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122257_bib44","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.biomaterials.2013.12.046","article-title":"Protein modified upconversion nanoparticles for imaging-guided combined photothermal and photodynamic therapy","volume":"35","author":"Chen","year":"2014","journal-title":"Biomaterials"},{"issue":"32","key":"10.1016\/j.biomaterials.2023.122257_bib45","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1002\/smll.201500550","article-title":"Photosensitizer-conjugated Albumin\u2212Polypyrrole nanoparticles for imaging-guided in vivo photodynamic\/photothermal therapy","volume":"11","author":"Song","year":"2015","journal-title":"Small"},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122257_bib46","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1016\/j.apsb.2022.08.013","article-title":"Smart drug delivery systems for precise cancer therapy","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"42","key":"10.1016\/j.biomaterials.2023.122257_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201804317","article-title":"Wax-sealed\u201d theranostic nanoplatform for enhanced afterglow imaging\u2013guided photothermally triggered photodynamic therapy","volume":"28","author":"Liu","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2023.122257_bib48","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jconrel.2020.10.030","article-title":"Serum protein-based nanoparticles for cancer diagnosis and treatment","volume":"329","author":"Iqbal","year":"2021","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122257_bib49","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1038\/ncomms9785","article-title":"Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy","volume":"6","author":"Cheng","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122257_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2144\/btn-2017-0110","article-title":"Restricted exchange microenvironments for cell culture","volume":"64","author":"Hoh","year":"2018","journal-title":"Biotechniques"},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122257_bib51","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/s41467-017-01651-9","article-title":"Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression","volume":"8","author":"Lu","year":"2017","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biomaterials.2023.122257_bib52","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nm.3931","article-title":"CD47 blockade triggers T cell\u2013mediated destruction of immunogenic tumors","volume":"21","author":"Liu","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2023.122257_bib53","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.2147\/IJN.S203383","article-title":"Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses","volume":"14","author":"Ma","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122257_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-020-00920-3","article-title":"High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies","volume":"13","author":"Yuan","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122257_bib55","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-065X.2007.00579.x","article-title":"The grateful dead: damage-associated molecular pattern molecules and reduction\/oxidation regulate immunity","volume":"220","author":"Lotze","year":"2007","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122257_bib56","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1021\/jacs.9b12232","article-title":"Modularly designed peptide nanoprodrug augments antitumor immunity of PD-L1 checkpoint blockade by targeting indoleamine 2,3-dioxygenase","volume":"142","author":"Han","year":"2020","journal-title":"J. Am. Chem. Soc."},{"issue":"38","key":"10.1016\/j.biomaterials.2023.122257_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201803001","article-title":"Binary cooperative prodrug nanoparticles improve immunotherapy by synergistically modulating immune tumor microenvironment","volume":"30","author":"Feng","year":"2018","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.biomaterials.2023.122257_bib58","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.3390\/cancers13122883","article-title":"Targeting HIF-1\u03b1 regulatory pathways as a strategy to hamper tumor-microenvironment interactions in CLL","volume":"13","author":"Vitale","year":"2021","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.biomaterials.2023.122257_bib59","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tcb.2014.06.001","article-title":"Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment","volume":"24","author":"Ackerman","year":"2014","journal-title":"Trends Cell Biol."},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122257_bib60","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/anie.201805664","article-title":"Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions","volume":"58","author":"Tang","year":"2019","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.biomaterials.2023.122257_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120388","article-title":"Ido-inhibitor potentiated immunogenic chemotherapy abolishes primary tumor growth and eradicates metastatic lesions by targeting distinct compartments within tumor microenvironment","volume":"269","author":"Li","year":"2021","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122257_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41467-020-20243-8","article-title":"Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.biomaterials.2023.122257_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201900927","article-title":"Light-triggered in situ gelation to enable robust photodynamic-immunotherapy by repeated stimulations","volume":"31","author":"Meng","year":"2019","journal-title":"Adv. Mater."},{"issue":"31","key":"10.1016\/j.biomaterials.2023.122257_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202203309","article-title":"Semiconducting polymer nanoparticles with surface-mimicking protein secondary structure as lysosome-targeting chimaeras for self-synergistic cancer immunotherapy","volume":"34","author":"Qi","year":"2022","journal-title":"Adv. Mater."},{"issue":"22","key":"10.1016\/j.biomaterials.2023.122257_bib65","article-title":"Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy","volume":"16","author":"Jiang","year":"2020","journal-title":"Small"},{"issue":"13","key":"10.1016\/j.biomaterials.2023.122257_bib66","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1021\/acs.nanolett.1c00818","article-title":"Tumor-associated-macrophage-membrane-coated nanoparticles for improved photodynamic immunotherapy","volume":"21","author":"Chen","year":"2021","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122257_bib67","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-019-11269-8","article-title":"Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122257_bib68","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nbt.3071","article-title":"Spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy","volume":"33","author":"Kim","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122257_bib69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nmat2357","article-title":"Infection-mimicking materials to Program dendritic cells in situ","volume":"8","author":"Ali","year":"2009","journal-title":"Nat. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122257_bib70","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T cell subsets","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat. Immunol."},{"issue":"40","key":"10.1016\/j.biomaterials.2023.122257_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201902960","article-title":"Self-amplified drug delivery with light-inducible nanocargoes to enhance cancer immunotherapy","volume":"31","author":"Feng","year":"2019","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122257_bib72","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1038\/s41467-021-24564-0","article-title":"Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"issue":"31","key":"10.1016\/j.biomaterials.2023.122257_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202101155","article-title":"Acidity-activatable dynamic nanoparticles boosting ferroptotic cell death for immunotherapy of cancer","volume":"33","author":"Song","year":"2021","journal-title":"Adv. Mater."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296122300265X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296122300265X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:25:36Z","timestamp":1758907536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296122300265X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":73,"alternative-id":["S014296122300265X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122257","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122257"}}